Vitamin B3 pill for glaucoma eye protection
Treatments studied
Part of Eyes & vision clinical trials.
This study tests whether a daily vitamin B3 pill (called nicotinamide) can help protect the optic nerve and slow down vision loss in people with glaucoma. If you're already managing glaucoma with eye drops or laser, this could be an option to preserve your sight.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Be between 40 and 80 years old
- Have open-angle glaucoma in at least one eye, with mild to moderate vision loss
- Be currently on a stable glaucoma treatment (like eye drops) for at least 4 months
- Not be taking vitamin B3 supplements (like nicotinamide), or other supplements such as Ginkgo biloba or CoQ10
- Receive your glaucoma care at the University of Chicago Medicine Eye Clinic
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether nicotinamide (a form of vitamin B3) can slow vision changes from open-angle glaucoma. It compares nicotinamide versus a placebo (inactive pill) in adults with early to moderate disease.
This trial tests whether a dietary supplement (DHA + citicoline) can help protect vision in people with glaucoma. You may qualify if you have confirmed glaucoma in at least one eye and are between 50 and 75 years old.
This Phase 3 trial tests whether citicoline 2% eye drops can help slow worsening of the visual field in adults with open-angle glaucoma. If you qualify, you would be monitored with repeated eye tests to see if your vision field stays more stable over time.
This trial tests a gene therapy treatment called GVB-2001 for people with primary open angle glaucoma. It involves a one-time injection into the eye to help lower eye pressure, and could be an option if you have tried other treatments that haven't worked well enough.
This trial tests whether a vitamin B3 supplement called nicotinamide can help slow down vision loss in people with glaucoma. It is for those with moderate disease who are already on treatment.
This study looks at whether a vitamin B3-related substance, called nicotinamide, is lower in the eyes and blood of people with glaucoma. It may help doctors understand why glaucoma damages the optic nerve.
Hear when a new Glaucoma, Open-Angle trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.